• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to "Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma".

作者信息

Feng Lan, Pang Wendu, Luo Yaxin, Ren Jianjun, Zhao Yu

机构信息

Department of Oto-Rhino-Laryngology, West China Hospital, Sichuan University, Chengdu, China.

Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.

出版信息

J Allergy Clin Immunol Pract. 2022 Oct;10(10):2778-2781. doi: 10.1016/j.jaip.2022.07.024.

DOI:10.1016/j.jaip.2022.07.024
PMID:36216468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9537751/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b5/9537751/4ae22805daf9/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b5/9537751/99e5698ed873/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b5/9537751/065b0316c6dc/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b5/9537751/4ae22805daf9/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b5/9537751/99e5698ed873/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b5/9537751/065b0316c6dc/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36b5/9537751/4ae22805daf9/gr3_lrg.jpg

相似文献

1
Reply to "Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma".对《吸入性和全身性皮质类固醇对哮喘患者 COVID-19 结局的不同影响》的回复
J Allergy Clin Immunol Pract. 2022 Oct;10(10):2778-2781. doi: 10.1016/j.jaip.2022.07.024.
2
Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma.吸入性和全身性皮质类固醇对哮喘患者新冠病毒疾病（COVID-19）结局的不同影响。
J Allergy Clin Immunol Pract. 2022 Oct;10(10):2777-2778. doi: 10.1016/j.jaip.2022.06.051.
3
Long COVID outcomes in an asthmatic cohort and its implications for asthma control.哮喘队列中的长期新冠病毒感染结局及其对哮喘控制的影响。
Respir Med. 2023 Feb;207:107092. doi: 10.1016/j.rmed.2022.107092. Epub 2022 Dec 16.
4
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.COVID-19 风险和结局在接受生物制剂或全身皮质类固醇治疗的成年哮喘患者中的：全国真实世界证据。
J Allergy Clin Immunol. 2021 Aug;148(2):361-367.e13. doi: 10.1016/j.jaci.2021.06.006. Epub 2021 Jun 15.
5
Inhaled corticosteroids for asthma: guidance is inconsistent.吸入性皮质类固醇治疗哮喘：指南并不一致。
BMJ. 2019 Dec 16;367:l6934. doi: 10.1136/bmj.l6934.
6
[PROPER USE OF INHALED CORTICOSTEROIDS IN ADULT PATIENTS WITH ASTHMA].[成人哮喘患者吸入性糖皮质激素的正确使用]
Arerugi. 2016;65(6):757-63. doi: 10.15036/arerugi.65.757.
7
Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship.吸入性糖皮质激素在哮喘中的气道和全身效应：剂量反应关系
Pulm Pharmacol. 1996 Feb;9(1):19-27. doi: 10.1006/pulp.1996.0002.
8
Effect of inhaled corticosteroids on linear growth in children with persistent asthma.吸入性糖皮质激素对持续性哮喘儿童线性生长的影响。
Paediatr Respir Rev. 2014 Dec;15(4):322-4. doi: 10.1016/j.prrv.2014.07.001. Epub 2014 Aug 4.
9
Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? Yes.在哮喘治疗中，是否应该使用抗白三烯疗法来替代吸入性糖皮质激素？答案是肯定的。
Am J Respir Crit Care Med. 1998 Dec;158(6):1697-8. doi: 10.1164/ajrccm.158.6.15860.
10
Recent drug-related adverse events with inhaled corticosteroids that should be considered in patients at risk.近期吸入性糖皮质激素相关的不良事件，高危患者应予以考虑。
Can J Clin Pharmacol. 1999 Summer;6(2):84.

本文引用的文献

1
Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma.吸入性和全身性皮质类固醇对哮喘患者新冠病毒疾病（COVID-19）结局的不同影响。
J Allergy Clin Immunol Pract. 2022 Oct;10(10):2777-2778. doi: 10.1016/j.jaip.2022.06.051.
2
Uncontrolled asthma predicts severe COVID-19: a report from the Swedish National Airway Register.未控制的哮喘预示着 COVID-19 重症：来自瑞典气道登记处的报告。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221091183. doi: 10.1177/17534666221091183.
3
Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort study.
苏格兰 5-17 岁哮喘儿童 COVID-19 住院风险：一项全国性发病队列研究。
Lancet Respir Med. 2022 Feb;10(2):191-198. doi: 10.1016/S2213-2600(21)00491-4. Epub 2021 Nov 30.
4
Impact of Allergic Rhinitis and Asthma on COVID-19 Infection, Hospitalization, and Mortality.过敏性鼻炎和哮喘对 COVID-19 感染、住院和死亡的影响。
J Allergy Clin Immunol Pract. 2022 Jan;10(1):124-133. doi: 10.1016/j.jaip.2021.10.049. Epub 2021 Oct 30.